Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by the chair and vice chair of NICE's highly specialised technologies evaluation committee.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

Chair

Paul Arundel
Chair, highly specialised technologies evaluation committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser and a project manager.

Giacomo De Guisa
Technical lead

Alan Moore
Technical adviser

Louise Jafferally
Project manager

Ross Dent
Associate director

ISBN: 978-1-4731-5746-0